News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,634 Results
Type
Article (54044)
Company Profile (325)
Press Release (718253)
Multimedia
Podcasts (103)
Webinars (19)
Section
Business (215139)
Career Advice (2198)
Deals (36958)
Drug Delivery (127)
Drug Development (84805)
Employer Resources (176)
FDA (17487)
Job Trends (15975)
News (364548)
Policy (35431)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2873)
Accelerated approval (34)
Adcomms (31)
Allergies (149)
Alliances (52758)
ALS (181)
Alzheimer's disease (1760)
Antibody-drug conjugate (ADC) (328)
Approvals (17735)
Artificial intelligence (574)
Autoimmune disease (173)
Automation (44)
Bankruptcy (375)
Best Places to Work (12217)
BIOSECURE Act (20)
Biosimilars (197)
Biotechnology (211)
Bladder cancer (163)
Brain cancer (61)
Breast cancer (669)
Cancer (5033)
Cardiovascular disease (431)
Career advice (1860)
Career pathing (39)
CAR-T (297)
CDC (52)
Celiac Disease (2)
Cell therapy (783)
Cervical cancer (38)
Clinical research (72162)
Collaboration (1818)
Company closure (4)
Compensation (1179)
Complete response letters (64)
COVID-19 (2890)
CRISPR (100)
C-suite (907)
Cystic fibrosis (147)
Data (6423)
Decentralized trials (2)
Denatured (41)
Depression (147)
Diabetes (520)
Diagnostics (7016)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (267)
Drug pricing (201)
Drug shortages (32)
Duchenne muscular dystrophy (237)
Earnings (92977)
Editorial (64)
Employer branding (21)
Employer resources (155)
Events (124137)
Executive appointments (1021)
FDA (20728)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (213)
Generative AI (54)
Gene therapy (633)
GLP-1 (1040)
Government (5039)
Grass and pollen (6)
Guidances (386)
Healthcare (20246)
HIV (66)
Huntington's disease (46)
IgA nephropathy (86)
Immunology and inflammation (272)
Immuno-oncology (63)
Indications (119)
Infectious disease (3179)
Inflammatory bowel disease (203)
Inflation Reduction Act (15)
Influenza (124)
Intellectual property (256)
Interviews (336)
IPO (17111)
IRA (54)
Job creations (4102)
Job search strategy (1560)
JPM (58)
Kidney cancer (17)
Labor market (87)
Layoffs (576)
Leadership (35)
Legal (8650)
Liver cancer (95)
Longevity (16)
Lung cancer (685)
Lymphoma (390)
Machine learning (44)
Management (60)
Manufacturing (842)
MASH (171)
Medical device (14906)
Medtech (14966)
Mergers & acquisitions (20935)
Metabolic disorders (1337)
Multiple sclerosis (169)
NASH (16)
Neurodegenerative disease (345)
Neuropsychiatric disorders (96)
Neuroscience (3075)
Neurotech (1)
NextGen: Class of 2026 (7055)
Non-profit (4837)
Now hiring (68)
Obesity (632)
Opinion (290)
Ovarian cancer (170)
Pain (209)
Pancreatic cancer (239)
Parkinson's disease (301)
Partnered (34)
Patents (517)
Patient recruitment (515)
Peanut (60)
People (62396)
Pharmaceutical (71)
Pharmacy benefit managers (31)
Phase 1 (22507)
Phase 2 (31678)
Phase 3 (23645)
Pipeline (5550)
Policy (307)
Postmarket research (2776)
Preclinical (9662)
Press Release (71)
Prostate cancer (249)
Psychedelics (52)
Radiopharmaceuticals (294)
Rare diseases (897)
Real estate (6438)
Recruiting (71)
Regulatory (26405)
Reports (53)
Research institute (2608)
Resumes & cover letters (379)
Rett syndrome (27)
RNA editing (16)
RSV (84)
Schizophrenia (157)
Series A (255)
Series B (201)
Service/supplier (13)
Sickle cell disease (100)
Special edition (24)
Spinal muscular atrophy (162)
Sponsored (44)
Startups (3926)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (87)
The Weekly (60)
Vaccines (1090)
Venture capital (95)
Weight loss (419)
Women's health (97)
Worklife (18)
Date
Last 7 days (587)
Last 30 days (2344)
Last 365 days (30756)
2026 (4141)
2025 (31208)
2024 (36428)
2023 (41512)
2022 (52791)
2021 (57536)
2020 (56379)
2019 (49400)
2018 (37419)
2017 (34285)
2016 (34212)
2015 (40253)
2014 (33973)
2013 (29332)
2012 (31601)
2011 (32267)
2010 (30643)
Location
Africa (842)
Alabama (86)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (43283)
Australia (7156)
California (11583)
Canada (3347)
China (1162)
Colorado (496)
Connecticut (509)
Delaware (349)
Europe (95370)
Florida (1729)
Georgia (380)
Hawaii (3)
Idaho (65)
Illinois (936)
India (72)
Indiana (539)
Iowa (23)
Japan (447)
Kansas (132)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1451)
Massachusetts (8419)
Michigan (338)
Minnesota (661)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (28)
Nevada (127)
New Hampshire (85)
New Jersey (3096)
New Mexico (31)
New York (3072)
North Carolina (1566)
North Dakota (9)
Northern California (5650)
Ohio (346)
Oklahoma (21)
Oregon (44)
Pennsylvania (2334)
Puerto Rico (24)
Rhode Island (50)
South America (1232)
South Carolina (69)
South Dakota (1)
Southern California (4510)
Tennessee (181)
Texas (1803)
United States (41531)
Utah (347)
Vermont (1)
Virginia (273)
Washington D.C. (84)
Washington State (969)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
772,634 Results for "merit medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merit Medical to Participate at the J.P. Morgan Healthcare Conference
December 24, 2025
·
1 min read
Press Releases
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
November 14, 2025
·
4 min read
Press Releases
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
October 31, 2025
·
31 min read
Press Releases
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
July 3, 2025
·
1 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
August 19, 2025
·
4 min read
Press Releases
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
·
28 min read
Press Releases
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
November 4, 2025
·
5 min read
Press Releases
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
August 8, 2025
·
5 min read
Business
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024.
June 18, 2024
·
1 min read
1 of 77,264
Next
